IQVIA HOLDINGS INC.

(IQV)
  Report
Delayed Nyse  -  05/20 04:04:30 pm EDT
201.83 USD   +0.04%
05/05TikoMed AB and IQVIA Announce Strategic Collaboration for the Development of TikoMed's Lead Drug Platform Candidate ILB®
CI
05/04TRANSCRIPT : IQVIA Holdings Inc. - Special Call
CI
04/29IQVIA Holdings Shares Rise Midday Following Piper Upgrade, Target Increase
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

IQVIA : Leslie Wims Morris Joins IQVIA Board of Directors - Form 8-K

01/27/2022 | 06:09am EDT

Leslie Wims Morris Joins IQVIA Board of Directors

RESEARCH TRIANGLE PARK, N.C. - January 24, 2022 - IQVIA (NYSE:IQV), a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, announced the appointment of Leslie Wims Morris to its board of directors, effective today.

With more than 25 years of experience in financial services, Wims Morris is currently Managing Director and Head of Corporate Development for JPMorgan Chase's Consumer & Community Banking business, which serves more than 60 million households in the U.S. In this role, she leads the development and launch of strategic partnerships with leading technology, payments, e-commerce and fintech companies and participates in firmwide strategic initiatives. She is also a member of the firm's investment committee.

"I am very pleased to welcome Leslie to our board of directors," said Ari Bousbib, chairman and CEO, IQVIA. "Her global experience managing strategic partnerships across a wide range of industries and deep investment expertise will provide a unique and valuable perspective to our company."

Wims Morris is a former Vice President of Executive Partnerships at American Express, Senior Vice President of Strategy and Business Development at Broadridge Financial Solutions and Senior Vice President at Jefferies & Company. She began her career as a Technology M&A Banker at Broadview International. During her career she has worked with numerous global Fortune 100 companies in the consumer retail, telecommunications, and technology industries to develop and execute innovative partnership strategies.

Passionate about the arts, she joined the board of the Dance Theatre of Harlem in 2010 and currently serves as Vice Chairman.

Wims Morris holds a Master of Business Administration from the Harvard Business School and a Bachelor of Arts in English from Yale University.

About IQVIA

IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence delivers powerful insights with speed and agility - enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 77,000 employees, IQVIA conducts operations in more than 100 countries.

IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA's insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.

# # #

Disclaimer

IQVIA Holdings Inc. published this content on 27 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 January 2022 11:08:08 UTC.


© Publicnow 2022
All news about IQVIA HOLDINGS INC.
05/05TikoMed AB and IQVIA Announce Strategic Collaboration for the Development of TikoMed's ..
CI
05/04TRANSCRIPT : IQVIA Holdings Inc. - Special Call
CI
04/29IQVIA Holdings Shares Rise Midday Following Piper Upgrade, Target Increase
MT
04/29Piper Sandler Lifts IQVIA Holdings to Overweight From Neutral, Price Target to $255 Fro..
MT
04/28IQVIA HOLDINGS INC. Management's Discussion and Analysis of Financial Condition and Re..
AQ
04/28Tranche Update on IQVIA Holdings Inc.'s Equity Buyback Plan announced on October 31, 20..
CI
04/28Stifel Nicolaus Adjusts Price Target for IQVIA Holdings to $271 From $297, Maintains Bu..
MT
04/28KeyBanc Adjusts IQVIA Holdings' Price Target to $250 from $290, Keeps Overweight Rating
MT
04/28IQVIA HOLDINGS INC. : SEC Filing 10Q-1
CO
04/28IQVIA HOLDINGS INC. : SEC Filing 10Q-1
CO
More news
Analyst Recommendations on IQVIA HOLDINGS INC.
More recommendations
Financials (USD)
Sales 2022 14 632 M - -
Net income 2022 1 291 M - -
Net Debt 2022 10 188 M - -
P/E ratio 2022 30,2x
Yield 2022 -
Capitalization 38 185 M 38 185 M -
EV / Sales 2022 3,31x
EV / Sales 2023 2,95x
Nbr of Employees 82 000
Free-Float 73,3%
Chart IQVIA HOLDINGS INC.
Duration : Period :
Iqvia Holdings Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IQVIA HOLDINGS INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 18
Last Close Price 201,74 $
Average target price 266,94 $
Spread / Average Target 32,3%
EPS Revisions
Managers and Directors
Ari Bousbib Chairman, President & Chief Executive Officer
Ronald Earl Bruehlman Chief Financial Officer & Executive Vice President
Karl Guenault Chief Information Officer & Senior Vice President
Jeffrey A. Spaeder Chief Medical & Scientific Officer
Costa Panagos President-Research & Development Solutions
Sector and Competitors
1st jan.Capi. (M$)
IQVIA HOLDINGS INC.-28.50%38 185
MODERNA, INC.-43.55%54 775
LONZA GROUP AG-29.81%40 137
SEAGEN INC.-7.74%26 323
ICON PUBLIC LIMITED COMPANY-30.82%16 524
CELLTRION, INC.-28.79%15 565